RM87.1mil for purchase of diabetes medication to benefit 280,231 patients, says Dr Dzul


PUTRAJAYA: An allocation of RM87.1mil under Budget 2025 for the purchase of sodium-glucose transport protein 2 (SGLT2) inhibitors will benefit 280,231 diabetic patients.

Health Minister Datuk Seri Dr Dzulkefly Ahmad said this will reduce complications for diabetic patients including cardiovascular and kidney complications which incur higher costs.

"This approach is in line with the shift of the Health Ministry (MOH) from 'sick-care' to 'health-care' to ensure the effectiveness and sustainability of the national health system in the long-term," he said in a statement on Monday (Nov 4).

Dr Dzulkefly said the MOH will also launch the Prevention and Control of Noncommunicable Diseases in Malaysia: The Case for Investment 2021 report, a collaboration with the World Bank, on Nov 14.

He said the "War on Sugar” campaign is a government initiative to reduce the intake of sugar among the people as a measure to tackle non-communicable diseases (NCDs) such as diabetes.

He said the Strategic Plan to Reduce Sugar Among Malaysians 2024-2030, launched on June 29, contains six main strategies, with 38 initiatives and 65 activities encompassing policies, advocacy and comprehensive public-private cooperation.

The Health Minister said cardiovascular disease, cancer, diabetes, and chronic respiratory diseases are silent killers and they contribute to 72 per cent of the total premature deaths in Malaysia.

"The burden of disease goes far beyond the issue of public health; it also places a burden on the country's economy," he said.

Quoting the Prevention and Control of Noncommunicable Diseases in Malaysia: The Case for Investment 2021 report, Dr Dzulkefly said the overall economic burden for the four NCDs -- cardiovascular disease, metabolic diseases particularly diabetes, cancer, and chronic respiratory diseases, is estimated at RM64.2bil.

"The economic burden includes the direct healthcare costs borne by the government, amounting to RM12.4bil each year, as well as indirect costs due to productivity loss from absenteeism, presenteeism and premature deaths," he said.

Dr Dzulkefly said the issue of presenteeism and absenteeism often arises due to diabetic complications such as fatigue, blurred vision and increased risk of infections.

He said cardiovascular disease and diabetes alone caused a loss of RM1.8bil in terms of absenteeism, while presenteeism amounted to RM30.2bil.

"In the long term, these will cause the country big economic losses due to the decline in workforce performance, productivity and economic competitiveness, as diabetes patients may have difficulty concentrating or meeting intensive work demands," he added. - Bernama

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Dzulkefly Ahmad , MOH , allocation , patients , NCDs

   

Next In Nation

Johor govt to seek views of taximen affected by NGV ruling
Flood mitigation progress slow on Malaysia's east coast
85% of M'sians won't be impacted by RON95 subsidy rationalisation, Dewan Rakyat told
Broader reforms needed with regard to safety on public transport, says social activist
Special op on motorcycles led to 10% drop in accidents, says Bukit Aman
Police to use drones to tackle cross-border crimes in Kelantan
Kelantan cops foil bid to smuggle shoes, handbags worth RM3.1mil
60 deaths, over 6,000 accidents reported during Deepavali period
Cops nab 48 following raids on unlicensed entertainment outlets in Kepong, Puchong
Plans in place to enhance cancer care, especially in rural areas, says Health Ministry

Others Also Read